The HSE will today enter the ‘final stages’ of talks to agree the price of a major new drug for Cystic Fibrosis.
Senior management will spend the rest of the week in discussions with Vertex over the cost of the drug Orkambi.
It’s been heralded as a ‘wonder drug’ for patients with CF, but it’s not available to Irish patients because of its price.
Health Minister Simon Harris is keen to agree costs, to guarantee value for the future:
